SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?

Mone, Pasquale, Michele Ciccarelli, Stanislovas S Jankauskas, Germano Guerra, Carmine Vecchione, Valeria Visco, and Gaetano Santulli. “SGLT2 Inhibitors and GLP-1 Receptor Agonists: Which Is the Best Anti-Frailty Drug?”. The Lancet. Healthy Longevity 5, no. 9 (2024): 100632.